Kopan and Sibley named to Wolff professorships

Two leading members of the faculty at Washington University School of Medicine in St. Louis have been named Alan A. and Edith L. Wolff Professors in their respective fields. Raphael Kopan, PhD, has been named the Wolff Professor of Developmental Biology, and David Sibley, PhD, has been named the Wolff Professor of Molecular Microbiology.

Washington People: Douglas L. Mann

Though some cardiologists may have dabbled in musical pursuits from an early age, few have opened for Aerosmith. How does one who dropped out of college to play drums and follow dreams of being a professional musician end up chief of cardiology at a major medical school? “I needed a day job,” says Douglas L. Mann, MD. Today, Mann studies inflammation and its role in heart failure.

Rare immune cell is asset and liability in fighting infection

The same trait that makes a rare immune cell invaluable in fighting some infections also can be exploited by other diseases to cause harm, two new studies show. By studying the basic functions of these cells, scientists are laying the groundwork to use them to fight infections. The cells also appear to be essential for some cancer vaccines, which enlist the power of the immune system to help fight tumors.

Siteman Cancer Research Fund names first two awardees

A newly established fund to support innovative cancer research at the Alvin J. Siteman Cancer Center has awarded its first two $900,000 grants to high-tech efforts to undermine cancer cells’ ability to resist treatment. The awards will help scientists use genetic data to find new ways to attack treatment-resistant breast cancer and precisely target treatments for various kinds of cancer cells based on their responses to radiation therapy.
Older Stories